IBDEI2LW ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41627,1,4,0)
;;=4^I69.354
;;^UTILITY(U,$J,358.3,41627,2)
;;=^5007507
;;^UTILITY(U,$J,358.3,41628,0)
;;=I69.151^^155^2061^39
;;^UTILITY(U,$J,358.3,41628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41628,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
;;^UTILITY(U,$J,358.3,41628,1,4,0)
;;=4^I69.151
;;^UTILITY(U,$J,358.3,41628,2)
;;=^5007441
;;^UTILITY(U,$J,358.3,41629,0)
;;=I69.152^^155^2061^37
;;^UTILITY(U,$J,358.3,41629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41629,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
;;^UTILITY(U,$J,358.3,41629,1,4,0)
;;=4^I69.152
;;^UTILITY(U,$J,358.3,41629,2)
;;=^5007442
;;^UTILITY(U,$J,358.3,41630,0)
;;=I69.153^^155^2061^40
;;^UTILITY(U,$J,358.3,41630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41630,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
;;^UTILITY(U,$J,358.3,41630,1,4,0)
;;=4^I69.153
;;^UTILITY(U,$J,358.3,41630,2)
;;=^5007443
;;^UTILITY(U,$J,358.3,41631,0)
;;=I69.154^^155^2061^38
;;^UTILITY(U,$J,358.3,41631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41631,1,3,0)
;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
;;^UTILITY(U,$J,358.3,41631,1,4,0)
;;=4^I69.154
;;^UTILITY(U,$J,358.3,41631,2)
;;=^5007444
;;^UTILITY(U,$J,358.3,41632,0)
;;=I69.851^^155^2061^45
;;^UTILITY(U,$J,358.3,41632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41632,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
;;^UTILITY(U,$J,358.3,41632,1,4,0)
;;=4^I69.851
;;^UTILITY(U,$J,358.3,41632,2)
;;=^5007535
;;^UTILITY(U,$J,358.3,41633,0)
;;=I69.852^^155^2061^46
;;^UTILITY(U,$J,358.3,41633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41633,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
;;^UTILITY(U,$J,358.3,41633,1,4,0)
;;=4^I69.852
;;^UTILITY(U,$J,358.3,41633,2)
;;=^5007536
;;^UTILITY(U,$J,358.3,41634,0)
;;=I69.853^^155^2061^47
;;^UTILITY(U,$J,358.3,41634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41634,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
;;^UTILITY(U,$J,358.3,41634,1,4,0)
;;=4^I69.853
;;^UTILITY(U,$J,358.3,41634,2)
;;=^5007537
;;^UTILITY(U,$J,358.3,41635,0)
;;=I69.854^^155^2061^48
;;^UTILITY(U,$J,358.3,41635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41635,1,3,0)
;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
;;^UTILITY(U,$J,358.3,41635,1,4,0)
;;=4^I69.854
;;^UTILITY(U,$J,358.3,41635,2)
;;=^5007538
;;^UTILITY(U,$J,358.3,41636,0)
;;=I69.251^^155^2061^49
;;^UTILITY(U,$J,358.3,41636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41636,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
;;^UTILITY(U,$J,358.3,41636,1,4,0)
;;=4^I69.251
;;^UTILITY(U,$J,358.3,41636,2)
;;=^5007473
;;^UTILITY(U,$J,358.3,41637,0)
;;=I69.252^^155^2061^50
;;^UTILITY(U,$J,358.3,41637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41637,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
;;^UTILITY(U,$J,358.3,41637,1,4,0)
;;=4^I69.252
;;^UTILITY(U,$J,358.3,41637,2)
;;=^5007474
;;^UTILITY(U,$J,358.3,41638,0)
;;=I69.253^^155^2061^51
;;^UTILITY(U,$J,358.3,41638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41638,1,3,0)
;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
;;^UTILITY(U,$J,358.3,41638,1,4,0)
;;=4^I69.253
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2LW 3746 printed Nov 22, 2024@17:41:27 Page 2
IBDEI2LW ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41627,1,4,0)
+2 ;;=4^I69.354
+3 ;;^UTILITY(U,$J,358.3,41627,2)
+4 ;;=^5007507
+5 ;;^UTILITY(U,$J,358.3,41628,0)
+6 ;;=I69.151^^155^2061^39
+7 ;;^UTILITY(U,$J,358.3,41628,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,41628,1,3,0)
+10 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
+11 ;;^UTILITY(U,$J,358.3,41628,1,4,0)
+12 ;;=4^I69.151
+13 ;;^UTILITY(U,$J,358.3,41628,2)
+14 ;;=^5007441
+15 ;;^UTILITY(U,$J,358.3,41629,0)
+16 ;;=I69.152^^155^2061^37
+17 ;;^UTILITY(U,$J,358.3,41629,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,41629,1,3,0)
+20 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
+21 ;;^UTILITY(U,$J,358.3,41629,1,4,0)
+22 ;;=4^I69.152
+23 ;;^UTILITY(U,$J,358.3,41629,2)
+24 ;;=^5007442
+25 ;;^UTILITY(U,$J,358.3,41630,0)
+26 ;;=I69.153^^155^2061^40
+27 ;;^UTILITY(U,$J,358.3,41630,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,41630,1,3,0)
+30 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
+31 ;;^UTILITY(U,$J,358.3,41630,1,4,0)
+32 ;;=4^I69.153
+33 ;;^UTILITY(U,$J,358.3,41630,2)
+34 ;;=^5007443
+35 ;;^UTILITY(U,$J,358.3,41631,0)
+36 ;;=I69.154^^155^2061^38
+37 ;;^UTILITY(U,$J,358.3,41631,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,41631,1,3,0)
+40 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
+41 ;;^UTILITY(U,$J,358.3,41631,1,4,0)
+42 ;;=4^I69.154
+43 ;;^UTILITY(U,$J,358.3,41631,2)
+44 ;;=^5007444
+45 ;;^UTILITY(U,$J,358.3,41632,0)
+46 ;;=I69.851^^155^2061^45
+47 ;;^UTILITY(U,$J,358.3,41632,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,41632,1,3,0)
+50 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
+51 ;;^UTILITY(U,$J,358.3,41632,1,4,0)
+52 ;;=4^I69.851
+53 ;;^UTILITY(U,$J,358.3,41632,2)
+54 ;;=^5007535
+55 ;;^UTILITY(U,$J,358.3,41633,0)
+56 ;;=I69.852^^155^2061^46
+57 ;;^UTILITY(U,$J,358.3,41633,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,41633,1,3,0)
+60 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
+61 ;;^UTILITY(U,$J,358.3,41633,1,4,0)
+62 ;;=4^I69.852
+63 ;;^UTILITY(U,$J,358.3,41633,2)
+64 ;;=^5007536
+65 ;;^UTILITY(U,$J,358.3,41634,0)
+66 ;;=I69.853^^155^2061^47
+67 ;;^UTILITY(U,$J,358.3,41634,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,41634,1,3,0)
+70 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
+71 ;;^UTILITY(U,$J,358.3,41634,1,4,0)
+72 ;;=4^I69.853
+73 ;;^UTILITY(U,$J,358.3,41634,2)
+74 ;;=^5007537
+75 ;;^UTILITY(U,$J,358.3,41635,0)
+76 ;;=I69.854^^155^2061^48
+77 ;;^UTILITY(U,$J,358.3,41635,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,41635,1,3,0)
+80 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
+81 ;;^UTILITY(U,$J,358.3,41635,1,4,0)
+82 ;;=4^I69.854
+83 ;;^UTILITY(U,$J,358.3,41635,2)
+84 ;;=^5007538
+85 ;;^UTILITY(U,$J,358.3,41636,0)
+86 ;;=I69.251^^155^2061^49
+87 ;;^UTILITY(U,$J,358.3,41636,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,41636,1,3,0)
+90 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
+91 ;;^UTILITY(U,$J,358.3,41636,1,4,0)
+92 ;;=4^I69.251
+93 ;;^UTILITY(U,$J,358.3,41636,2)
+94 ;;=^5007473
+95 ;;^UTILITY(U,$J,358.3,41637,0)
+96 ;;=I69.252^^155^2061^50
+97 ;;^UTILITY(U,$J,358.3,41637,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,41637,1,3,0)
+100 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
+101 ;;^UTILITY(U,$J,358.3,41637,1,4,0)
+102 ;;=4^I69.252
+103 ;;^UTILITY(U,$J,358.3,41637,2)
+104 ;;=^5007474
+105 ;;^UTILITY(U,$J,358.3,41638,0)
+106 ;;=I69.253^^155^2061^51
+107 ;;^UTILITY(U,$J,358.3,41638,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,41638,1,3,0)
+110 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
+111 ;;^UTILITY(U,$J,358.3,41638,1,4,0)
+112 ;;=4^I69.253
